tert-Butyl (cis-3-hydroxycyclobutyl)carbamate
97%
- Product Code: 146163
CAS:
389890-43-1
Molecular Weight: | 187.24 g./mol | Molecular Formula: | C₉H₁₇NO₃ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules where a protected cyclobutylamine scaffold is required. The tert-butyl carbamate (Boc) group provides stability during multi-step reactions and can be easily removed under mild acidic conditions, allowing for further functionalization. The cis-hydroxy substituent on the cyclobutane ring offers a handle for additional derivatization, making this compound valuable in medicinal chemistry for constructing constrained ring systems that can enhance potency, selectivity, or metabolic stability in drug candidates. Commonly employed in the preparation of kinase inhibitors, CNS-active agents, and other small-molecule therapeutics.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
5.000 | 10-20 days | $112.27 |
+
-
|
10.000 | 10-20 days | $192.23 |
+
-
|
25.000 | 10-20 days | $398.06 |
+
-
|
50.000 | 10-20 days | $793.57 |
+
-
|
100.000 | 10-20 days | $1,568.01 |
+
-
|
tert-Butyl (cis-3-hydroxycyclobutyl)carbamate
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of biologically active molecules where a protected cyclobutylamine scaffold is required. The tert-butyl carbamate (Boc) group provides stability during multi-step reactions and can be easily removed under mild acidic conditions, allowing for further functionalization. The cis-hydroxy substituent on the cyclobutane ring offers a handle for additional derivatization, making this compound valuable in medicinal chemistry for constructing constrained ring systems that can enhance potency, selectivity, or metabolic stability in drug candidates. Commonly employed in the preparation of kinase inhibitors, CNS-active agents, and other small-molecule therapeutics.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :